OCUL financials
Ocular Therapeutix (OCUL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
OCUL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $51.82M | $45.25M | -$270.02M | -$265.94M | -1.42 |
| 2024 | $63.72M | $58.10M | -$171.78M | -$193.51M | -1.22 |
| 2023 | $58.44M | $53.16M | -$82.38M | -$80.74M | -1.02 |
| 2022 | $51.49M | $46.95M | -$78.65M | -$71.04M | -0.97 |
| 2021 | $43.52M | $39.12M | -$78.04M | -$6.55M | -0.98 |
| 2020 | $17.40M | $15.32M | -$62.85M | -$155.64M | -2.56 |
- OCUL revenue was $51.82M in fiscal 2025, net income -$265.94M.
Updated 2026-11-03 12:35 UTC